Immediate Impact
9 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
A catalytic alkene insertion approach to bicyclo[2.1.1]hexane bioisosteres
2023 Standout
Works of Jan Philipp Jonas being referenced
5-FU based chemotherapy with bevacizumab in synchronous metastatic colorectal cancer patients with bleeding primary tumor.
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jan Philipp Jonas | 9 | 21 | 5 | 16 | 32 | |
| А. А. Карпов | 6 | 19 | 6 | 23 | 28 | |
| F.J. Tejero-Pintor | 17 | 17 | 5 | 9 | 31 | |
| Amine Sebai | 9 | 24 | 7 | 25 | 26 | |
| Gamal Amira | 12 | 26 | 8 | 10 | 34 | |
| Belén Matías‐García | 16 | 22 | 9 | 13 | 43 | |
| Szilárd Gódi | 12 | 17 | 7 | 11 | 30 | |
| Perrone | 6 | 14 | 6 | 12 | 30 | |
| Carlos Zavaleta-Corvera | 4 | 17 | 3 | 15 | 21 | |
| Sung-Min Ahn | 10 | 17 | 7 | 17 | 51 | |
| Giuseppe Tarantini | 5 | 16 | 6 | 12 | 55 |
All Works
Login with ORCID to disown or claim papers
Loading papers...